Psoriasis Patients' Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom

Juan Gonzalez; F Johnson; F Mughal

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept

Psoriasis Patients' Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom

Gonzalez, J., Johnson, F., & Mughal, F. (2013). Psoriasis Patients' Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom. Value in Health, 16(7), A508-A508.

Copy citation

Recent Publications

Article

The daily association between affect and alcohol use: A meta-analysis of individual participant data

Article

The use of patient experience feedback in rehabilitation quality improvement and codesign activities

Article

Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen

Article

Psoriasis Patients' Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom

Publications Info

Recent Publications

The daily association between affect and alcohol use: A meta-analysis of individual participant data

The use of patient experience feedback in rehabilitation quality improvement and codesign activities

Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen

SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia

Partner With Us

Site